Literature DB >> 36258703

Acquired Immune Deficiency Syndrome Cholangiopathy: Case Series of Three Patients and Literature Review.

Yasir Ahmed1, Mustafeez Ur Rahman2, Zoia Ehsan Khattak3, Jorge Herrera4, Eduardo Calderon5.   

Abstract

Cholangiopathy in acquired immune deficiency syndrome (AIDS) is being less frequently reported since antiretroviral therapy (ART) is available. It is associated with an advanced disease and seen in situations with poor access or non-compliance with ART. Liver biopsy is thought to have low yield in cases of AIDS cholangiopathy, but it can be an important tool in diagnosis, especially early in the course of the disease. The prognosis of AIDS cholangiopathy is generally not favorable, the therapy for opportunistic infections is mostly ineffective and restoration of immune system with ART remains the therapy of choice. We are sharing our experience of diagnosing and managing three cases of AIDS cholangiopathy. Copyright 2022, Ahmed et al.

Entities:  

Keywords:  AIDS cholangiopathy; Antiretroviral therapy; HIV/AIDS; Opportunistic infections

Year:  2022        PMID: 36258703      PMCID: PMC9534195          DOI: 10.14740/jmc3998

Source DB:  PubMed          Journal:  J Med Cases        ISSN: 1923-4155


  45 in total

Review 1.  Abdominal and pelvic CT in the HIV-positive population.

Authors:  L R Carucci; R A Halvorsen
Journal:  Abdom Imaging       Date:  2004-06-16

2.  Biliary tract obstruction in the acquired immunodeficiency syndrome.

Authors:  S J Margulis; C L Honig; R Soave; A F Govoni; J A Mouradian; I M Jacobson
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

3.  AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients.

Authors:  Y Benhamou; E Caumes; Y Gerosa; J F Cadranel; E Dohin; C Katlama; P Amouyal; J M Canard; N Azar; C Hoang
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

Review 4.  Hepatobiliary and pancreatic infections in AIDS: Part one.

Authors:  A P Keaveny; M S Karasik
Journal:  AIDS Patient Care STDS       Date:  1998-05       Impact factor: 5.078

5.  Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.

Authors:  R G Hewitt; C T Yiannoutsos; E S Higgs; J T Carey; P J Geiseler; R Soave; R Rosenberg; G J Vazquez; L J Wheat; R J Fass; Z Antoninievic; A L Walawander; T P Flanigan; J F Bender
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

6.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

7.  HIV/AIDS cholangiopathy: clinical spectrum, cholangiographic features and outcome in 30 patients.

Authors:  Harshad Devarbhavi; Teena Sebastian; Sandeep M Seetharamu; Dheeraj Karanth
Journal:  J Gastroenterol Hepatol       Date:  2010-10       Impact factor: 4.029

8.  Cytomegalovirus cholangitis and pancreatitis in an immunocompetent patient.

Authors:  Takatomi Oku; Masahiro Maeda; Eriko Waga; Yuko Wada; Yasuhiro Nagamachi; Miri Fujita; Yasuhiro Suzuki; Kazuo Nagashima; Yoshiro Niitsu
Journal:  J Gastroenterol       Date:  2005-10       Impact factor: 7.527

9.  Sonographic prediction of a normal or abnormal ERCP in suspected AIDS related sclerosing cholangitis.

Authors:  C A Daly; S P Padley
Journal:  Clin Radiol       Date:  1996-09       Impact factor: 2.350

10.  Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy.

Authors:  J M Molina; E Oksenhendler; B Beauvais; C Sarfati; A Jaccard; F Derouin; J Modaï
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.